Resources

Cocaine use in the United States has begun to rise in the past few years, and indicators suggest it will continue to rise, at greater levels, in the coming years. This issue brief is designed to help prevention practitioners better understand and prevent this growing problem.

Presents resources for preparing first responders to distribute and/or administer naloxone, including community-based programs; prescribers and pharmacists; and law enforcement, firefighters, and emergency medical services.

This practice-support tool identifies the different agencies responsible for prescribing and distributing prescription opioids in a community.

This resource describes recent trends in and factors associated with heroin use, including the non-medical use of prescription opioids. To facilitate substance misuse prevention planning at the state and local levels, the brief also includes information on data sources for heroin-related indicators and strategies that show promise in reducing rates of heroin use and overdose.

An at-a-glance resource to help prevention practitioners better understand and prevent the growing problem of Neonatal Abstinence Syndrome (NAS).

Presents a list of 16 key data sources for prescription opioids and heroin to inform assessment and planning efforts.

This whitepaper presents five concrete steps businesses can take to support employees and colleagues affected by opioid use and establish a workplace that is safe, compassionate, and productive.

This decision-support tool provides information on data sources and measures to help practitioners understand the non-medical use of prescription drugs in their communities.

This decision-support tool presents key findings from a review of current research on the non-medical use of prescription drugs, including a summary of risk and protective factors associated with prescription drug misuse, as well as programs and strategies that have been shown to be effective in addressing these factors.

This decision support tool provides brief summaries of prevention strategies and associated programs that have been evaluated to determine their effects on the non-medical use of prescription drugs, including an overview of the relevant literature, descriptions of individual studies, and guidelines for using this information to inform prevention planning efforts.